It has recently been shown that lenalidomide inhibits CLL-cell proliferation induced by CD154 + IL-4 + IL-10 in a cereblon/p21-dependent manner but independently of p53 [57]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.